Skip navigation
Skip navigation
You are using an outdated browser. Please upgrade your browser.
Floortje van Nooten PhD

Dublin, Ireland - October, 2022 – Terebellum, subsidiary of AscellaHealth, a global specialty pharmacy and healthcare solutions organisation, has announced the appointment of two executive positions to drive its growth in the UK and EU.

A Vice President of Market Access & Commercialisation and a dedicated Regional Director join Ireland and UK-based Terebellum as it expands its international footprint to offer life sciences expertise throughout Europe.

Craig Caceci, Executive Vice President and Managing Director of Terebellum, said: “Accelerated growth has prompted the need to attract additional business development and market access talent to expand our international footprint, as well as build upon our strategic market access, distribution and supply chain experience and expertise gained over the past ten years.”

Newly appointed Vice President of Market Access & Commercialisation, Floortje van Nooten PhD, brings with her almost 20 years of experience in the biopharmaceutical industry. Floortje will lead Terebellum’s expansion into the UK and EU, collaborating with marketing leadership on value proposition and messaging strategy, while providing guidance and support on consultative sales strategies and the development of client solutions.

Prior to joining the business Floortje delivered market access value strategies and led the development of reimbursement and pricing strategies across Europe and in the US, as Head of Global Market Access at ProQR.

Floortje also led worldwide market access and pricing strategies and negotiations at Biocryst and Dompé, from product pre-launch through to post-launch, and led global market access and health economics and outcomes research strategies for Astellas.

Victoria Daet MBA also joins Terebellum, with a breadth of business development and sales experience across many countries including the UK, Singapore, Thailand and Japan.

As Regional Director, Victoria will identify opportunities within public and private healthcare organisations and develop commercialisation and go-to-market strategies for rare/orphan disease and gene/cell therapy pharmaceutical manufacturers in the EU and UK.

Prior to her appointment, Victoria was the product marketing lead for Singapore-based firm OMG Network, a fintech ICO unicorn, handling product and feature launches and the identification of leads to push into the business development pipeline.

In Japan, Victoria held both business development and executive marketing leadership roles driving sales and growth strategies for Slush, a world leading big-tech conference.

Along with the entire Terebellum leadership team, Floortje and Victoria will apply their broad industry expertise to provide strategic innovation and consultative market access support to pharmaceutical manufacturers and healthcare organisations.

Craig Caceci adds, “Our commitment to providing innovative solutions to life sciences companies which serve to improve medication access, reduce costs, and enhance clinical outcomes for patients with complex chronic conditions and rare diseases remains consistent.

“The market-leading experience and expertise Floortje and Victoria bring to Terebellum will drive innovation and growth in the programmes, consultation and market access support provided to our partners across the UK and Europe.”

Terebellum’s services include pre-commercialisation and market access support, distribution and fulfilment, supply chain logistics, pharmaceutical financial solutions, and custom clinical and pull-through programmes.

- ends -

Photo captions

Floortje van Nooten PhD,
Vice President of Market Access & Commercialisation – Terebellum

Victoria Daet MBA,
Regional Director - Terebellum

About Terebellum

Terebellum is an Ireland and UK based subsidiary of AscellaHealth representing our global footprint throughout Europe. Our premier group purchasing services, market access expertise, supply chain logistics, and unique pharmaceutical financial solutions, targeted to life sciences partners and other industry stakeholders ensure optimal cost savings and enhanced clinical outcomes. Terebellum’s leadership team has the extensive expertise needed to provide a consultative approach for branded specialty products to be brought to market successfully. Visit

About The AscellaHealth Family of Companies

The AscellaHealth Family of Companies, comprised of AscellaHealth and subsidiaries Optime Care and Terebellum, is a global healthcare and specialty pharmacy solutions organisation serving specialty and rare disease patients, healthcare organisations, life sciences manufacturers and providers with solutions addressing the unmet needs in this dynamic marketplace. A unique patient-first mission and dedication to improved medication access and outcomes are woven throughout integrated end-to-end solutions that span the entire pharmaceutical lifecycle and beyond. Visit


Media enquiries

Joanna Marshall, Senior Consultant, Viva PR.
Tel: +44 (0) 1706 214340 Mob: +44 (0) 7540 634815 Email:

Marketing enquiries

Darcey McDermott, Chief Marketing and Communications Officer, AscellaHealth. Email:

This press release was distributed by ResponseSource Press Release Wire on behalf of Viva PR in the following categories: Health, Business & Finance, Medical & Pharmaceutical, for more information visit